EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy

Tianpeng Zheng, Shanglong Wang, Wukun Liu iD, Yunlong Lu iD

Journal of Medicinal Chemistry · 23.01.2025 · 68 (2) · 1002-1020

DOI: 10.1021/acs.jmedchem.4c02613 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 06.01.2025. Verfasst von Tianpeng Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine,…. Hauptthemen laut MEDLINE: Histone Acetyltransferases, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Jiangsu Provincial Key Research and Development Program, Nanjing University of Chinese Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone AcetyltransferasesAntineoplastic AgentsNeoplasmsHumansAnimalsEnzyme Inhibitors

Substanzen

KAT6A protein, humanHistone AcetyltransferasesAntineoplastic AgentsEnzyme Inhibitors

Autor:innen und Institutionen

  • Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.

ORCID-Profile: Wukun Liu, Yunlong Lu

Förderung

  • Jiangsu Provincial Key Research and Development Program
  • Nanjing University of Chinese Medicine
  • National Natural Science Foundation of China
  • Jiangsu Commission of Health
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • High level key discipline construction project of the National Administration of Traditional Chinese Medicine-Resource Chemistry of Chinese Medicinal Materials

Zitieren

APA

Zheng, T., Wang, S., Liu, W., & Lu, Y. (2025). Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy. Journal of Medicinal Chemistry, 68(2), 1002-1020. https://doi.org/10.1021/acs.jmedchem.4c02613

Vancouver

Zheng T, Wang S, Liu W, Lu Y. Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy. Journal of Medicinal Chemistry. 2025;68(2):1002-1020. doi:10.1021/acs.jmedchem.4c02613

BibTeX
@article{Zheng2025,
  author = {Zheng, Tianpeng and Wang, Shanglong and Liu, Wukun and Lu, Yunlong},
  title = {Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {2},
  pages = {1002--1020},
  doi = {10.1021/acs.jmedchem.4c02613}
}
Kostenlos starten →